HealthMore in Health→
Aspirin Fails to Prevent Recurrence After Colorectal Cancer Liver Metastases
Key Takeaways
- The ASAC trial tested aspirin after treatment for colorectal cancer liver metastases.
- The randomized, double-blind, placebo-controlled study found no recurrence-prevention benefit.
- The result challenges expectations based on earlier observational studies.
DE
DT Editorial Team··via medicalxpress.com